RGS RGS Healthcare Solutions

Guides

Tender results, volumes and holders, explained

Short, practical guides to the questions commercial teams ask about European pharmaceutical tenders: how to find who won, how to estimate volumes that are not stated, how licence holders differ from manufacturers, and what to look for in tender intelligence software.

Guide

How to Choose Pharma Tender Intelligence Software

Choose on what happens after a tender closes. The useful questions are whether it shows the winner and the published bid prices per strength, separates stated from...

Read the guide
Guide

How to Find Who Won a Pharmaceutical Tender in Europe

The winner appears in the buyer's award notice or award decision, published after the standstill period. Many buyers name the winner but not every bidder's price,...

Read the guide
Guide

How to Estimate Tender Volumes When They Are Not Stated

Treat any volume in a tender as a starting point. Many buyers publish estimates, frame volumes as maximums, or leave them out. A better estimate combines the stated...

Read the guide
Guide

Licence Holder vs Manufacturer: Who Really Makes a Generic?

The marketing authorisation holder is the company legally responsible for a medicine in a market. The manufacturer is the company that makes and releases it. For...

Read the guide
Guide

Tender Visibility for Partner-Led Generics Manufacturers

When partners hold the licences and bid in tenders, the manufacturer sees the outcome only in its order book. Mapping each partner's products and markets to tenders,...

Read the guide
Guide

How Pharmaceutical Tenders Work in Europe

European medicines are tendered by hospitals, hospital purchasing groups, regional or national central bodies and, in some countries, health insurers. Each tender is...

Read the guide
Guide

Award Notice Without a Winner or Price: Why It Happens

EU rules require an award notice within 30 days of signing a contract, but let buyers withhold details whose release would harm commercial interests or fair...

Read the guide
Guide

Why Did We Lose the Tender? Debriefs and Standstill Rules

Under EU rules, a rejected bidder can ask the buyer in writing for the reasons for rejection and, if its offer was admissible, the characteristics and relative...

Read the guide
Guide

How to Price a Generic Tender Bid

Start from your own floor, the lowest price you can supply at, then look at what actually won before for the same molecule, buyer type and lot structure. Adjust for...

Read the guide
Guide

Medicine Framework Agreements: Call-Offs, Mini-Competitions

A framework agreement sets prices and terms with one or more suppliers for up to four years, and the buyer orders during that time. With one supplier, orders go...

Read the guide
Explainer

Critical Medicines Act: What Changes in Medicine Tenders

The Critical Medicines Act is an EU regulation agreed provisionally in 2026 and not yet in force. For medicines on the EU list of critical medicines, it would push...

Read the guide
Resource

CPV Codes for Medicines: the 33600000 Group Explained

Medicine tenders in the EU are classified under CPV 33600000 (pharmaceutical products), split into subgroups that broadly follow the ATC therapeutic groups, such as...

Read the guide
Resource

Medicine Buyers in Europe: Purchasing Bodies by Country

In most European countries, hospital medicines are bought by regional or national purchasing bodies and hospital groups. Germany and the Netherlands add health...

Read the guide
MedTech

Medical Device Tenders in Europe: Buyers, Criteria, Results

Medical devices, diagnostics and consumables are tendered by hospitals, hospital groups and central purchasing bodies across Europe, usually under CPV group 33100000...

Read the guide

Looking for a single term? Browse the tender glossary or read how each market tenders

Prefer to see it on your own data?

Book a short demo and we will answer these questions for your molecules and markets.